FDA, FTC Issue Warnings to Delta 8 Copycat Cannabis Companies
Last week, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent out warning letters to six different […]
Last week, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent out warning letters to six different […]
Cannabis brands are facing a proverbial fork in the road: determining whether their product evolves into a luxury consumable or affordable agricultural […]
There are a lot of risks throughout the entire supply chain in the cannabis and hemp markets. Legal and regulatory issues, quality […]
The Case for Automation in the Cannabis Industry History has shown that if companies fail to innovate when new technology emerges, even […]
2023 has so far been a productive year for the New Jersey Cannabis Regulatory Commission (CRC), the government body tasked with overseeing […]
May 4, 2022 – Registration for the Cannabis Quality Conference & Expo (CQC), taking place October 16-18 at the Hilton Parsippany in New […]
In 2022, product liability lawsuits in the cannabis/cannabidiol (CBD) industry continued to focus on levels of THC and the psychoactive ingredient in […]
2023 Cannabis Labs Virtual Conference: February Program Click here to watch the recording Agenda When & Why You Should use Molecular-Based vs. […]
According to a press release emailed this week, ASTM International’s subcommittee focused on cannabis, D37, is in the midst of developing two […]
On December 20, 2018, Former President Trump signed the Farm Bill into law, which removed hemp-derived cannabidiol (CBD) from the Controlled Substances […]